• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Stem Cell Therapy—Avoid the Scam

October 9, 2018 By Dr. Jeremy Feldman

scam alert

It has been some time since I last wrote about avoiding Stem Cell Therapy.  Recently several of my patients have been suckered into this trap. Stem cells are bone marrow derived cells that have the potential to divide and become cells of any part of our body.  There is great promise in trying to understand how to develop effective treatments that use these cells.  … [Read more...]

Medical Marijuana and Pulmonary Arterial Hypertension

September 24, 2018 By Dr. Jeremy Feldman

medical marijuana for pulmonary hypertension

Despite federal law that continues to classify marijuana as illegal, many states have legalized marijuana for medical use and some states for recreational use.  The internet is full of impressive claims about the healing powers of marijuana and CBD oil and marijuana has become an enormous business that has moved from the street corner to the drug store. Fact and … [Read more...]

C76 Approved For Studies in Pulmonary Hypertension

September 20, 2018 By Dr. Jeremy Feldman

pulmonary hypertension research laboratory

Pulmonary arterial hypertension at its core is a disease of abnormal lung blood vessel behavior. While our currently available therapies have successfully improved the quality of life of our patients and extended their life expectancy, we still have a long way to go.  PAH patients unfortunately still often face progressive symptoms over time. What is the C76 Molecule? The FDA … [Read more...]

Surgi-Center and Endoscopy Procedures in Patients with Pulmonary Arterial Hypertension

August 28, 2018 By Dr. Jeremy Feldman

surgery operating room

A common problem that I encounter in the office is when a patient with PAH needs to have a procedure such as colonoscopy, upper endoscopy or orthopedic surgery.  For the average healthy person, these procedures represent minimal risk and can be done in outpatient endoscopy centers or at orthopedic hospitals. However, for patients with PAH or other advanced lung diseases these … [Read more...]

Recent Clinical Trial Results with Orenitram

August 24, 2018 By Dr. Jeremy Feldman

treatment laboratory

After six years, the FREEDOM-EV clinical trial has finished and preliminary results have been released. This study included patients with PAH who were already on a single oral therapy (either a PDE 5 inhibitor or an ERA). They were then randomized to have either a placebo or Orenitram added to their regimen.  Although we don’t have all of the final results, United Therapeutics … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Dr. Jeremy Feldman

FAQ’s: CTEPH, Blood Clots, Corrective Surgery, PAH Centers

By Dr. Jeremy Feldman

Your Questions Answered Who should be worried about CTEPH? Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

PAH Awareness

It’s November Again, Which Means Pulmonary Hypertension Awareness Month

By Dr. Jeremy Feldman

Since November is Pulmonary Hypertension Awareness month, we like to reflect on the progress made on this site and in

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives